Dongming Liu
Tianjin Medical University Cancer Institute and Hospital(CN)Henan Energy & Chemical Industry Group (China)(CN)Nanjing Brain Hospital(CN)Nanjing Drum Tower Hospital(CN)Henan Agricultural University(CN)Nagoya University(JP)Virginia Tech(US)
Publications by Year
Research Areas
Advances in Cucurbitaceae Research, Plant Molecular Biology Research, Hepatocellular Carcinoma Treatment and Prognosis, Chromosomal and Genetic Variations, Protein Kinase Regulation and GTPase Signaling
Most-Cited Works
- Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.(2001)
- → Paired Design of dCas9 as a Systematic Platform for the Detection of Featured Nucleic Acid Sequences in Pathogenic Strains(2016)182 cited
- Preclinical and clinical pharmacodynamic assessment of L-778,123, a dual inhibitor of farnesyl:protein transferase and geranylgeranyl:protein transferase type-I.(2002)
- → Changes in and challenges regarding the surgical treatment of hepatocellular carcinoma in China(2021)95 cited
- → PNO1 inhibits autophagy-mediated ferroptosis by GSH metabolic reprogramming in hepatocellular carcinoma(2022)73 cited
- → LDLR inhibition promotes hepatocellular carcinoma proliferation and metastasis by elevating intracellular cholesterol synthesis through the MEK/ERK signaling pathway(2021)73 cited
- → Imidazole-containing diarylether and diarylsulfone inhibitors of farnesyl-protein transferase